1492 related articles for article (PubMed ID: 15037527)
1. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
[TBL] [Abstract][Full Text] [Related]
2. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease.
Honold J; Lehmann R; Heeschen C; Walter DH; Assmus B; Sasaki K; Martin H; Haendeler J; Zeiher AM; Dimmeler S
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2238-43. PubMed ID: 16902165
[TBL] [Abstract][Full Text] [Related]
3. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia.
Finney MR; Greco NJ; Haynesworth SE; Martin JM; Hedrick DP; Swan JZ; Winter DG; Kadereit S; Joseph ME; Fu P; Pompili VJ; Laughlin MJ
Biol Blood Marrow Transplant; 2006 May; 12(5):585-93. PubMed ID: 16635794
[TBL] [Abstract][Full Text] [Related]
4. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb.
Zhang H; Zhang N; Li M; Feng H; Jin W; Zhao H; Chen X; Tian L
Ann Vasc Surg; 2008 Mar; 22(2):238-47. PubMed ID: 18083329
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy.
Sasaki K; Heeschen C; Aicher A; Ziebart T; Honold J; Urbich C; Rossig L; Koehl U; Koyanagi M; Mohamed A; Brandes RP; Martin H; Zeiher AM; Dimmeler S
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14537-41. PubMed ID: 16983080
[TBL] [Abstract][Full Text] [Related]
7. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure.
Kissel CK; Lehmann R; Assmus B; Aicher A; Honold J; Fischer-Rasokat U; Heeschen C; Spyridopoulos I; Dimmeler S; Zeiher AM
J Am Coll Cardiol; 2007 Jun; 49(24):2341-9. PubMed ID: 17572250
[TBL] [Abstract][Full Text] [Related]
8. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease.
Walter DH; Haendeler J; Reinhold J; Rochwalsky U; Seeger F; Honold J; Hoffmann J; Urbich C; Lehmann R; Arenzana-Seisdesdos F; Aicher A; Heeschen C; Fichtlscherer S; Zeiher AM; Dimmeler S
Circ Res; 2005 Nov; 97(11):1142-51. PubMed ID: 16254213
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.
Wang CH; Ciliberti N; Li SH; Szmitko PE; Weisel RD; Fedak PW; Al-Omran M; Cherng WJ; Li RK; Stanford WL; Verma S
Circulation; 2004 Mar; 109(11):1392-400. PubMed ID: 14993120
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of bone marrow-derived mononuclear cells in ischemic apolipoprotein E-knockout mice accelerates atherosclerosis without altering plaque composition.
Silvestre JS; Gojova A; Brun V; Potteaux S; Esposito B; Duriez M; Clergue M; Le Ricousse-Roussanne S; Barateau V; Merval R; Groux H; Tobelem G; Levy B; Tedgui A; Mallat Z
Circulation; 2003 Dec; 108(23):2839-42. PubMed ID: 14656923
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
[TBL] [Abstract][Full Text] [Related]
12. Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3.
Waeckel L; Mallat Z; Potteaux S; Combadière C; Clergue M; Duriez M; Bao L; Gerard C; Rollins BJ; Tedgui A; Levy BI; Silvestre JS
Circ Res; 2005 Mar; 96(5):576-82. PubMed ID: 15718500
[TBL] [Abstract][Full Text] [Related]
13. Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells.
Urbich C; Heeschen C; Aicher A; Dernbach E; Zeiher AM; Dimmeler S
Circulation; 2003 Nov; 108(20):2511-6. PubMed ID: 14581410
[TBL] [Abstract][Full Text] [Related]
14. CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia.
Seeger FH; Rasper T; Koyanagi M; Fox H; Zeiher AM; Dimmeler S
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1802-9. PubMed ID: 19696399
[TBL] [Abstract][Full Text] [Related]
15. Caveolin plays a central role in endothelial progenitor cell mobilization and homing in SDF-1-driven postischemic vasculogenesis.
Sbaa E; Dewever J; Martinive P; Bouzin C; Frérart F; Balligand JL; Dessy C; Feron O
Circ Res; 2006 May; 98(9):1219-27. PubMed ID: 16601228
[TBL] [Abstract][Full Text] [Related]
16. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
17. Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response.
Zen K; Okigaki M; Hosokawa Y; Adachi Y; Nozawa Y; Takamiya M; Tatsumi T; Urao N; Tateishi K; Takahashi T; Matsubara H
J Mol Cell Cardiol; 2006 Jun; 40(6):799-809. PubMed ID: 16678200
[TBL] [Abstract][Full Text] [Related]
18. Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy.
Assmus B; Tonn T; Seeger FH; Yoon CH; Leistner D; Klotsche J; Schächinger V; Seifried E; Zeiher AM; Dimmeler S
J Am Coll Cardiol; 2010 Mar; 55(13):1385-94. PubMed ID: 20338501
[TBL] [Abstract][Full Text] [Related]
19. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro.
Isaikina Y; Kustanovich A; Svirnovski A
Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907
[TBL] [Abstract][Full Text] [Related]
20. Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease.
Liguori A; Fiorito C; Balestrieri ML; Crimi E; Bruzzese G; Williams-Ignarro S; D'Amora M; Sommese L; Grimaldi V; Minucci PB; Giovane A; Farzati B; Ignarro LJ; Napoli C
Eur J Haematol; 2008 Mar; 80(3):258-64. PubMed ID: 18081701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
